Company
abrdn Inc
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Abcuro | Series D | 2026-08-18 | |
| Crystalys Therapeutics | Series A | 2025-09-30 | |
| Glycomine | Series C | 2025-04-16 | Lead |
| Abcuro | Series C | 2025-02-13 | |
| Atalanta Therapeutics | Series B | 2025-01-28 |
Company
| Company | Round | Date | Lead |
|---|---|---|---|
| Abcuro | Series D | 2026-08-18 | |
| Crystalys Therapeutics | Series A | 2025-09-30 | |
| Glycomine | Series C | 2025-04-16 | Lead |
| Abcuro | Series C | 2025-02-13 | |
| Atalanta Therapeutics | Series B | 2025-01-28 |